Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study

doi:10.3748/wjg.v24.i38.4403

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 38

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6322)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

554

HTML

3134

Figures (1-3)

172

Tables (1-5)

155

Sum=4015

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

882

Download

1425

Sum=2307

Oct 14, 2018 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Oct 14, 2018; 24(38): 4403-4411
Published online Oct 14, 2018. doi: 10.3748/wjg.v24.i38.4403

Open in New Tab Full Size Figure Download Figure

Figure 1 Overall trends in waiting list registrations and liver transplantations at Padua University Hospital in the study period. WL: Waiting list; LT: Liver transplantation.

Open in New Tab Full Size Figure Download Figure

Figure 2 Trends in waiting list registration before and after direct-acting antiviral introduction. ALD: Alcoholic liver disease; DAA: Direct-acting antivirals; HBV: Hepatitis B virus; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; NASH: Non-alcoholic steatohepatitis.

Open in New Tab Full Size Figure Download Figure

Figure 3 Trends in liver transplantation before and after direct-acting antiviral introduction. ALD: Alcoholic liver disease; DAA: Direct-acting antivirals; HBV: Hepatitis B virus; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; NASH: Non-alcoholic steatohepatitis.

Citation: Ferrarese A, Germani G, Gambato M, Russo FP, Senzolo M, Zanetto A, Shalaby S, Cillo U, Zanus G, Angeli P, Burra P. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study. World J Gastroenterol 2018; 24(38): 4403-4411
URL: https://www.wjgnet.com/1007-9327/full/v24/i38/4403.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i38.4403